Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line

被引:211
|
作者
Essletzbichler, Patrick [1 ]
Konopka, Tomasz [2 ]
Santoro, Federica [1 ]
Chen, Doris [2 ]
Gapp, Bianca V. [2 ]
Kralovics, Robert [2 ]
Brummelkamp, Thijn R. [2 ,3 ]
Nijman, Sebastian M. B. [1 ,2 ]
Buerckstuemmer, Tilmann [1 ]
机构
[1] Haplogen GmbH, A-7030 Vienna, Austria
[2] Austrian Acad Sci CeMM, Res Ctr Mol Med, A-7090 Vienna, Austria
[3] Netherlands Canc Inst, NL-7066 CX Amsterdam, Netherlands
关键词
EMBRYONIC STEM-CELLS; CHROMOSOMAL DELETIONS; GENETIC SCREENS; CAS9; INVERSIONS; NUCLEASES; CRISPR-CAS9; DERIVATION; LEUKEMIA;
D O I
10.1101/gr.177220.114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Near-haploid human cell lines are instrumental for genetic screens and genome engineering as gene inactivation is greatly facilitated by the absence of a second gene copy. However, no completely haploid human cell line has been described, hampering the genetic accessibility of a subset of genes. The near-haploid human cell line HAP1 contains a single copy of all chromosomes except for a heterozygous 30-megabase fragment of Chromosome 15. This large fragment encompasses 330 genes and is integrated on the long arm of Chromosome 19. Here, we employ a CRISPR/Cas9-based genome engineering strategy to excise this sizeable chromosomal fragment and to efficiently and reproducibly derive clones that retain their haploid state. Importantly, spectral karyotyping and single-nucleotide polymorphism (SNP) genotyping revealed that engineered-HAPloid (eHAP) cells are fully haploid with no gross chromosomal aberrations induced by Cas9. Furthermore, whole-genome sequence and transcriptome analysis of the parental HAP1 and an eHAP cell line showed that transcriptional changes are limited to the excised Chromosome 15 fragment. Together, we demonstrate the feasibility of efficiently engineering megabase deletions with the CRISPR/Cas9 technology and report the first fully haploid human cell line.
引用
收藏
页码:2059 / 2065
页数:7
相关论文
共 50 条
  • [1] CRISPR-Cas9 genome editing induces megabase-scale deletions
    Cullot, G.
    Boutin, J.
    Prat, F.
    Dabernat, S.
    Richard, E.
    Bedel, A.
    Moreau-Gaudry, F.
    HUMAN GENE THERAPY, 2019, 30 (11) : A186 - A186
  • [2] CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
    Cullot, Gregoire
    Boutin, Julian
    Toutain, Jerome
    Prat, Florence
    Pennamen, Perrine
    Rooryck, Caroline
    Teichmann, Martin
    Rousseau, Emilie
    Lamrissi-Garcia, Isabelle
    Guyonnet-Duperat, Veronique
    Bibeyran, Alice
    Lalanne, Magalie
    Prouzet-Mauleon, Valerie
    Turcq, Beatrice
    Ged, Cecile
    Blouin, Jean-Marc
    Richard, Emmanuel
    Dabernat, Sandrine
    Moreau-Gaudry, Francois
    Bedel, Aurelie
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [3] Comparison of CRISPR-Cas9-mediated megabase-scale genome deletion methods in mouse embryonic stem cells
    Miyata, Masayuki
    Yoshida, Junko
    Takagishi, Itsuki
    Horie, Kyoji
    DNA RESEARCH, 2023, 30 (01)
  • [4] CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
    Grégoire Cullot
    Julian Boutin
    Jérôme Toutain
    Florence Prat
    Perrine Pennamen
    Caroline Rooryck
    Martin Teichmann
    Emilie Rousseau
    Isabelle Lamrissi-Garcia
    Véronique Guyonnet-Duperat
    Alice Bibeyran
    Magalie Lalanne
    Valérie Prouzet-Mauléon
    Béatrice Turcq
    Cécile Ged
    Jean-Marc Blouin
    Emmanuel Richard
    Sandrine Dabernat
    François Moreau-Gaudry
    Aurélie Bedel
    Nature Communications, 10
  • [5] Generation of megabase-scale deletions, inversions and duplications involving the Contactin-6 gene in mice by CRISPR/Cas9 technology
    Alexei N. Korablev
    Irina A. Serova
    Oleg L. Serov
    BMC Genetics, 18
  • [6] Generation of megabase-scale deletions, inversions and duplications involving the Contactin-6 gene in mice by CRISPR/Cas9 technology
    Korablev, Alexei N.
    Serova, Irina A.
    Serov, Oleg L.
    BMC GENETICS, 2017, 18
  • [7] CRISPR/Cas9 Genome Nuclease Editing Induces Megabase Scale Chromosomal Truncations
    Moreau-Gaudry, Francois
    Cullot, Gregoire
    Boutin, Julian
    Toutain, Jerome
    Pennamen, Perrine
    Rooryck, Caroline
    Teichmann, Martin
    Lamrissi-Garcia, Isabelle
    Guyonnet-Duperat, Veronique
    Lalanne, Magalie
    Prouzet-Mauleon, Valerie
    Turcq, Beatrice
    Ged, Cecile
    Blouin, Jean-Marc
    Richard, Emmanuel
    Dabernat, Sandrine
    Bedel, Aurelie
    MOLECULAR THERAPY, 2019, 27 (04) : 108 - 108
  • [8] Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9
    Cullot, G.
    Boutin, J.
    Fayet, S.
    Prat, F.
    Rosier, J.
    Cappellen, D.
    Lamrissi, I.
    Pennamen, P.
    Bouron, J.
    Amintas, S.
    Thibault, C.
    Moranvillier, I.
    Laharanne, E.
    Merlio, J. P.
    Guyonnet-Duperat, V.
    Blouin, J. M.
    Richard, E.
    Dabernat, S.
    Moreau-Gaudry, F.
    Bedel, A.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [9] Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9
    G. Cullot
    J. Boutin
    S. Fayet
    F. Prat
    J. Rosier
    D. Cappellen
    I. Lamrissi
    P. Pennamen
    J. Bouron
    S. Amintas
    C. Thibault
    I. Moranvillier
    E. Laharanne
    J. P. Merlio
    V. Guyonnet-Duperat
    J. M. Blouin
    E. Richard
    S. Dabernat
    F. Moreau-Gaudry
    A. Bedel
    Nature Communications, 14
  • [10] Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models
    Draper, Garrett M.
    Panken, Daniel J.
    Largaespada, David A.
    GENES CHROMOSOMES & CANCER, 2023, 62 (09): : 493 - 500